PT  - JOURNAL ARTICLE
AU  - Paz, Valentina
AU  - Dashti, Hassan S.
AU  - Garfield, Victoria
TI  - Is there an association between daytime napping and cognitive function? A Mendelian randomisation study in the UK Biobank
AID  - 10.1101/2021.09.28.21264215
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.28.21264215
4099  - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264215.short
4100  - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264215.full
AB  - Background Daytime napping has been associated with cognitive function in observational studies. However, it remains elusive whether napping could be beneficial or detrimental for cognition and whether these associations are causal.Methods Using Mendelian randomisation (MR), we studied the relationship between daytime napping and cognitive outcomes. Data were from UK Biobank (n= 378,932; mean age= 57 years). Our exposure (daytime napping) was instrumented using 92 genome-wide, independent genetic variants and our cognitive outcomes were reaction time and visual memory. Inverse-variance weighted MR was implemented, with sensitivity analyses including MR-Egger and the Weighted Median Estimator for horizontal pleiotropy. We also tested different daytime napping instruments (47 SNPs, 86 SNPs and 17 SNPs) to ensure the robustness of our results.Results No associations were found between daytime napping and reaction time (expß=1.01, 95%CI=1.00; 1.03), or visual memory (expß=0.99, 95%CI=0.94; 1.05). MR-Egger and Weighted Median Estimator approaches showed no evidence of horizontal pleiotropy. Additional analyses with 47 SNPs (adjusted for excessive daytime sleepiness), 86 SNPs (excluding sleep apnoea) and 17 SNPs (no sample overlap with UKB) also showed no associations with reaction time or visual memory.Conclusions Overall, we observed no evidence of a causal association between habitual daytime napping and reaction time and visual memory. Future studies should focus on the associations between napping and other cognitive outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Programa de Desarrollo de las Ciencias Basicas (PEDECIBA, MEC-UdelaR, Uruguay) [to VP]; Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) [grant number MOV_CA_2020_1_163153 to VP]; Comision Sectorial de Investigacion Cientifica (CSIC, UdelaR, Uruguay) [to VP]; Comision Academica de Posgrados (CAP, UdelaR, Uruguay) [to VP]; National Heart, Lung, and Blood Institute (NHLBI) [grant number K99HL153795 to HSD]; Diabetes UK and British Heart Foundation [grant number 15/0005250 to VG].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was conducted under the approved UK Biobank project number 71702All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe UK Biobank data are publicly available to all bona fide researchers at https://www.ukbiobank.ac.uk